MediciNova
MNOV
26 hedge funds and large institutions have $6.49M invested in MediciNova in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
13% more funds holding
Funds holding: 23 → 26 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.09% less ownership
Funds ownership: 10.54% → 10.46% (-0.09%)
4% less capital invested
Capital invested by funds: $6.77M → $6.49M (-$286K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$94.2K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.9K |
| 3 |
Renaissance Technologies
New York
|
+$17.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.93K |
| 5 |
BlackRock
New York
|
+$4.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$165K |
| 2 |
Barclays
London,
United Kingdom
|
-$25.1K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$6.46K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3.87K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.62K |
MNOV Hedge Fund Activity: Q3 2025 in Review
26 institutional investors reported a position in MediciNova (MNOV) for Q3 2025, worth a combined $6.49M — down 4.2% from $6.77M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new MNOV positions and 1 closed out — a net gain of 3 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $94.2K. The largest seller was Susquehanna International Group, cutting an estimated $165K.
- 26 institutional investors held MediciNova (MNOV) as of Q3 2025, up from 23 in Q2 2025.
- Funds reported $6.49M of MediciNova stock for Q3 2025, down 4.2% quarter-over-quarter.
- 4 funds opened new MediciNova positions in Q3 2025 and 1 closed out, a net change of +3 holders.
- The largest MediciNova buyer in Q3 2025 was Citadel Advisors, an estimated $94.2K added.
- The largest MediciNova seller in Q3 2025 was Susquehanna International Group, an estimated $165K sold.
Based on aggregated 13F filings for Q3 2025.